Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 127, 163-177
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 110 references indexed in Scilit:
- A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusionJournal of Neuroinflammation, 2013
- Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse modelBMC Neuroscience, 2013
- Neurotoxicity of Amyloid -Protein: Synaptic and Network DysfunctionCold Spring Harbor Perspectives in Medicine, 2012
- Gains or losses: molecular mechanisms of TDP43-mediated neurodegenerationNature Reviews Neuroscience, 2011
- Tau Reduction Prevents Aβ-Induced Defects in Axonal TransportScience, 2010
- Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153Journal of Biological Chemistry, 2010
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationActa Neuropathologica, 2007
- Targeted delivery of proteins across the blood–brain barrierProceedings of the National Academy of Sciences, 2007
- Double-knockout mice for α- and β-synucleins: Effect on synaptic functionsProceedings of the National Academy of Sciences, 2004
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000